HFpEF mimics: hypertrophic cardiomyopathy in light of the 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction

Hypertrophic cardiomyopathy is a genetic condition which leads to myocardial hypertrophy. Main cause of death in a group of patients with this disease is sudden cardiac death. In this article we present a diagnostic path which is consistent with the American College of Cardiology Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction diagnostic path. This led to diagnosis of hypertrophic cardiomyopathy and classifying it to the newly established amongst heart failure with preserved ejection fraction group — HFpEF mimics.